Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12364631rdf:typepubmed:Citationlld:pubmed
pubmed-article:12364631lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12364631lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:12364631lifeskim:mentionsumls-concept:C0264939lld:lifeskim
pubmed-article:12364631lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:12364631lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:12364631lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:12364631pubmed:issue10lld:pubmed
pubmed-article:12364631pubmed:dateCreated2002-10-4lld:pubmed
pubmed-article:12364631pubmed:abstractTextEvidence indicates that tumour necrosis factor (TNF) is a major agent in the pathogenesis of vasculitis. We studied the short-term effect of anti-TNF-alpha antibody in systemic vasculitis patients refractory to steroids and immunosuppressive agents.lld:pubmed
pubmed-article:12364631pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:languageenglld:pubmed
pubmed-article:12364631pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12364631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12364631pubmed:statusMEDLINElld:pubmed
pubmed-article:12364631pubmed:monthOctlld:pubmed
pubmed-article:12364631pubmed:issn1462-0324lld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:CohenPPlld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:GuillevinLLlld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:MahnEElld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:Le HelloCClld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:BartolucciPPlld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:GodmerPPlld:pubmed
pubmed-article:12364631pubmed:authorpubmed-author:RamanoelinaJJlld:pubmed
pubmed-article:12364631pubmed:issnTypePrintlld:pubmed
pubmed-article:12364631pubmed:volume41lld:pubmed
pubmed-article:12364631pubmed:ownerNLMlld:pubmed
pubmed-article:12364631pubmed:authorsCompleteYlld:pubmed
pubmed-article:12364631pubmed:pagination1126-32lld:pubmed
pubmed-article:12364631pubmed:dateRevised2007-9-6lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:meshHeadingpubmed-meshheading:12364631...lld:pubmed
pubmed-article:12364631pubmed:year2002lld:pubmed
pubmed-article:12364631pubmed:articleTitleEfficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.lld:pubmed
pubmed-article:12364631pubmed:affiliationDepartment of Internal Medicine, French Vasculitis Study Group, UPRES Recherche Clinique et Thérapeutique, Hôpital Avicenne, Assistance Publique Hôpitaux de Paris, 125 route de Stalingrad, 93000 Bobigny, France.lld:pubmed
pubmed-article:12364631pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12364631pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12364631lld:pubmed